Both companies are betting big on Asia and investors are wondering which company will provide the best returns.
Let’s take a look at Sun Life and Manulife to see if one is a better bet right now.
Sun Life Financial
Sun Life has been operating in Asia for a long time and the company is starting to see the fruits of those efforts.
In the fourth quarter of 2014 Sun Life’s Asian operations reported net income of of $62 million compared to $42 million in the same period in 2013. Asia represented 8% of Sun Life’s 2014 revenue.
The company operates in India, China, Hong Kong, Indonesia, Vietnam, Malaysia, and the Philippines. These markets together represent about 70% of Asia’s total population.
The company offers life insurance products in all of the countries and is expanding its asset management and group benefits services in the region.
One opportunity that stands out today is India. The company has been building a strong business in the country for more than 15 years through its Birla Sun Life joint partnership. at the end of 2014 the business had $21.5 billion in assets under management (AUM).
A recent decision by the Indian government to increase investment limits for foreign insurers is great news for Sun Life. International companies will be allowed to own 49% of local partnerships, up from 26%. The government expects the new rule to bring in as much as $2 billion in new investment in the first 12 months. Birla Sun Life is already India’s sixth-largest insurer and the company should continue to make headway into the $60 billion market.
The stock currently trades at 11 times forward earnings, which is attractive compared to its five-year average.
Manulife has been quite active recently in its efforts to boost its Asian presence. On April 8 Manulife announced a US$1.2 billion deal with Singapore-based DBS Bank Ltd. that will give Manulife exclusive distribution of its products to DBS’s large Asian banking franchise.
The 15-year agreement takes effect next year and Manulife expects the deal to be accretive to earnings in 2017. The two companies will sell Manulife’s insurance and wealth management products to customers in Singapore, China, Hong Kong, and Indonesia. Manulife also has a strong presence in Japan, Vietnam, and the Philippines.
In India Manulife will probably enter the market through its recent alliance with Standard Life Plc, which already operates in the country. Manulife just completed a $4 billion acquisition of Standard Life’s Canadian assets and the deal also includes an agreement to cross-sell each other’s products around the globe.
In 2014 Manulife’s Asian operations represented 18% of total premiums and deposits and accounted for 13% of AUM. Insurance sales in the region increased 31%, and wealth sales rose 2% compared with 2013.
Manulife trades at a reasonable 10.7 times forward earnings.
Which should you buy?
Both companies should do well in Asia in the long run. If you think India offers the best opportunity, Sun Life is better positioned to capitalize on the new investment limits. Manulife’s new deal with DBS could be a catalyst for strong growth, but investors will have to wait to see if the deal works out as well as expected.
Buying a good turnaround stock like Manulife or Sun Life can bring substantial long-term rewards, but you have to get the timing right. The Motley Fool Canada team is always hard at work looking for top companies that have battled through hard times and are finally ready to rocket higher.
Our analysts recently identified one such stock and today we are offering the complete report for free to all of our readers.
Our TOP turnaround stock for 2015—you don’t want to miss this!
When companies fall from grace like this Canadian icon did, it’s typically impossible to regain relevance. Here at Motley Fool Canada, we think this company is about to prove all the critics are wrong. We have even named it our TOP turnaround stock for 2015.
If you’re a curious soul (like me), you can download the name, ticker symbol, and price guidance absolutely FREE.
Fool contributor Andrew Walker has no position in any stocks mentioned.